308 related articles for article (PubMed ID: 24728270)
1. An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation.
Hohnloser SH; Connolly SJ; John Camm A; Halperin JL; Radzik D
Europace; 2014 Aug; 16(8):1117-24. PubMed ID: 24728270
[TBL] [Abstract][Full Text] [Related]
2. Interaction between digoxin and dronedarone in the PALLAS trial.
Hohnloser SH; Halperin JL; Camm AJ; Gao P; Radzik D; Connolly SJ;
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1019-25. PubMed ID: 25378467
[TBL] [Abstract][Full Text] [Related]
3. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure.
Chatterjee S; Ghosh J; Lichstein E; Aikat S; Mukherjee D
Am J Cardiol; 2012 Aug; 110(4):607-13. PubMed ID: 22608952
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dronedarone: a review of randomized trials.
Christiansen CB; Torp-Pedersen C; Køber L
Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
[TBL] [Abstract][Full Text] [Related]
6. Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial.
Pisters R; Hohnloser SH; Connolly SJ; Torp-Pedersen C; Naditch-Brûlé L; Page RL; Crijns HJ;
Europace; 2014 Feb; 16(2):174-81. PubMed ID: 24072451
[TBL] [Abstract][Full Text] [Related]
7. Drug safety evaluation of dronedarone in atrial fibrillation.
De Ferrari GM; Dusi V
Expert Opin Drug Saf; 2012 Nov; 11(6):1023-45. PubMed ID: 22971242
[TBL] [Abstract][Full Text] [Related]
8. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
9. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
Salam AM
Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1345-9. PubMed ID: 23244355
[TBL] [Abstract][Full Text] [Related]
10. Dronedarone: an emerging therapy for atrial fibrillation.
Rosei EA; Salvetti M
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
[TBL] [Abstract][Full Text] [Related]
11. Outcomes with Dronedarone in Atrial Fibrillation: What Differences Between Real-World Practice and Trials? A Meta-Analysis and Meta-Regression Analysis.
Diemberger I; Massaro G; Reggiani MLB; Lorenzetti S; Biffi M; Ziacchi M; Martignani C; Boriani G
Curr Pharm Des; 2017; 23(6):944-951. PubMed ID: 27719634
[TBL] [Abstract][Full Text] [Related]
12. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
Duray GZ; Schmitt J; Hohnloser SH
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
[TBL] [Abstract][Full Text] [Related]
13. Dronedarone in high-risk permanent atrial fibrillation.
Connolly SJ; Camm AJ; Halperin JL; Joyner C; Alings M; Amerena J; Atar D; Avezum Á; Blomström P; Borggrefe M; Budaj A; Chen SA; Ching CK; Commerford P; Dans A; Davy JM; Delacrétaz E; Di Pasquale G; Diaz R; Dorian P; Flaker G; Golitsyn S; Gonzalez-Hermosillo A; Granger CB; Heidbüchel H; Kautzner J; Kim JS; Lanas F; Lewis BS; Merino JL; Morillo C; Murin J; Narasimhan C; Paolasso E; Parkhomenko A; Peters NS; Sim KH; Stiles MK; Tanomsup S; Toivonen L; Tomcsányi J; Torp-Pedersen C; Tse HF; Vardas P; Vinereanu D; Xavier D; Zhu J; Zhu JR; Baret-Cormel L; Weinling E; Staiger C; Yusuf S; Chrolavicius S; Afzal R; Hohnloser SH;
N Engl J Med; 2011 Dec; 365(24):2268-76. PubMed ID: 22082198
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
Hohnloser SH; Connolly SJ; Crijns HJ; Page RL; Seiz W; Torp-Petersen C
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):69-73. PubMed ID: 18031520
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF
J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618
[TBL] [Abstract][Full Text] [Related]
16. Dronedarone: an overview.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
[TBL] [Abstract][Full Text] [Related]
17. Dronedarone--a new alternative for management of atrial fibrillation.
Hundal M; Garg RK
Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):47-53. PubMed ID: 20001929
[TBL] [Abstract][Full Text] [Related]
18. Dronedarone: a promising alternative for the management of atrial fibrillation.
Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dronedarone as a therapeutic option for patients with atrial fibrillation.
Lee EJ; Kim J
J Clin Pharm Ther; 2014 Apr; 39(2):112-7. PubMed ID: 24738113
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland.
Åkerborg Ö; Nilsson J; Bascle S; Lindgren P; Reynolds M
Clin Ther; 2012 Aug; 34(8):1788-802. PubMed ID: 22770643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]